The relationship between bile acids levels and the prognosis of patients with diabetes on maintenance hemodialysis: a retrospective study

References

• Menke A, Casagrande S, Geiss L, et al. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. Jama. 2015;314(10):1–9. doi: 10.1001/jama.2015.10029.
   Web of Science ®Google Scholar
• Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi: 10.1016/j.diabres.2021.109119.
   PubMed Web of Science ®Google Scholar
• Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–1982. doi: 10.1016/S0140-6736(14)61601-9.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhao MH, Zuo L, et al. China kidney disease network (CK-NET) 2015 annual data report. Kidney Int Suppl (2011). 2019;9(1):e1–e81. doi: 10.1016/j.kisu.2018.11.001.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–952. doi: 10.1016/S0140-6736(04)17018-9.
   PubMed Web of Science ®Google Scholar
• Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–352. doi: 10.1016/S0140-6736(13)60595-4.
   PubMed Web of Science ®Google Scholar
• Ma L, Zhao S. Risk factors for mortality in patients undergoing hemodialysis: a systematic review and meta-analysis. Int J Cardiol. 2017;238:151–158. doi: 10.1016/j.ijcard.2017.02.095.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Yu Y, Yang Y, et al. Impacts of age, diabetes, gender, and access type on costs associated with vascular access among chinese patients on hemodialysis. Int J Artif Organs. 2021;44(5):302–309. doi: 10.1177/0391398820962112.
   PubMed Web of Science ®Google Scholar
• Brønden A, Albér A, Rohde U, et al. The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes. Diabetes Obes Metab. 2018;20(2):362–369. doi: 10.1111/dom.13080.
   PubMed Web of Science ®Google Scholar
• Kusumoto Y, Irie J, Iwabu K, et al. Bile acid binding resin prevents fat accumulation through intestinal microbiota in high-fat diet-induced obesity in mice. Metabolism. 2017;71:1–6. doi: 10.1016/j.metabol.2017.02.011.
   PubMed Web of Science ®Google Scholar
• Deng L, Chen X, Zhong Y, et al. Activation of TGR5 partially alleviates high glucose-Induced cardiomyocyte injury by inhibition of inflammatory responses and oxidative stress. Oxid Med Cell Longev. 2019;2019:6372786. doi: 10.1155/2019/6372786.
   PubMed Web of Science ®Google Scholar
• Foretz M, Guigas B, Viollet B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol. 2019;15(10):569–589. doi: 10.1038/s41574-019-0242-2.
   PubMed Web of Science ®Google Scholar
• Brønden A, Knop FK. Gluco-metabolic effects of pharmacotherapy-induced modulation of bile acid physiology. J Clin Endocrinol Metabol. 2020;105(1):362–373. doi: 10.1210/clinem/dgz025.
   Web of Science ®Google Scholar
• Albaugh VL, Banan B, Ajouz H, et al. Bile acids and bariatric surgery. Mol Aspects Med. 2017;56:75–89. doi: 10.1016/j.mam.2017.04.001.
   PubMed Web of Science ®Google Scholar
• Xu G, Song M. Recent advances in the mechanisms underlying the beneficial effects of bariatric and metabolic surgery. Surg Obes Relat Dis. 2021;17(1):231–238. doi: 10.1016/j.soard.2020.08.028.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen C, Xie C, et al. Serum bile acid response to oral glucose is attenuated in patients with early type 2 diabetes and correlates with 2-hour plasma glucose in individuals without diabetes. Diabetes Obes Metab. 2022;24(6):1132–1142. doi: 10.1111/dom.14683.
   PubMed Web of Science ®Google Scholar
• Sang M, Xie C, Qiu S, et al. Cholecystectomy is associated with dysglycaemia: cross-sectional and prospective analyses. Diabetes Obes Metab. 2022;24(8):1656–1660. doi: 10.1111/dom.14730.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhou A, Tang L, et al. Bile acids: key regulators and novel treatment targets for type 2 diabetes. J Diabetes Res. 2020;2020:6138438. doi: 10.1155/2020/6138438.
   PubMed Web of Science ®Google Scholar
• Duong TV, Wu PY, Wong TC, et al. Mid-arm circumference, body fat, nutritional and inflammatory biomarkers, blood glucose, dialysis adequacy influence all-cause mortality in hemodialysis patients: a prospective cohort study. Medicine. 2019;98(12):e14930. doi: 10.1097/MD.0000000000014930.
   PubMed Web of Science ®Google Scholar
• Shafi T, Sozio SM, Plantinga LC, et al. Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients. Diabetes Care. 2013;36(6):1522–1533. doi: 10.2337/dc12-1896.
   PubMed Web of Science ®Google Scholar
• Kim DK, Ko GJ, Choi YJ, et al. Glycated hemoglobin levels and risk of all-cause and cause-specific mortality in hemodialysis patients with diabetes. Diabetes Res Clin Pract. 2022;190:110016. doi: 10.1016/j.diabres.2022.110016.
   PubMed Web of Science ®Google Scholar
• Song YH, Cai GY, Xiao YF, et al. Risk factors for mortality in elderly haemodialysis patients: a systematic review and meta-analysis. BMC Nephrol. 2020;21(1):377. doi: 10.1186/s12882-020-02026-x.
   PubMed Web of Science ®Google Scholar
• van Gelder MK, Abrahams AC, Joles JA, et al. Albumin handling in different hemodialysis modalities. Nephrol Dial Transplant. 2018;33(6):906–913. doi: 10.1093/ndt/gfx191.
   PubMed Web of Science ®Google Scholar
• Cooper BA, Penne EL, Bartlett LH, et al. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis. 2004;43(1):61–66. doi: 10.1053/j.ajkd.2003.08.045.
   PubMed Web of Science ®Google Scholar
• Zitt E, Kirsch AH, Haueis M, et al. The PTH (1-84)/non-PTH (1-84) ratio is a risk factor for cardiovascular events in hemodialysis patients. Clin Nephrol. 2011;75(4):309–318. doi: 10.5414/cnp75309.
   PubMed Web of Science ®Google Scholar
• Hageman J, Herrema H, Groen AK, et al. A role of the bile salt receptor FXR in atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30(8):1519–1528. doi: 10.1161/ATVBAHA.109.197897.
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Cariou B, Lien F, et al. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev. 2009;89(1):147–191. doi: 10.1152/physrev.00010.2008.
   PubMed Web of Science ®Google Scholar
• Nakano T, Hiyamuta H, Yotsueda R, et al. Higher cholesterol level predicts cardiovascular event and inversely associates with mortality in hemodialysis patients: 10-year outcomes of the Q-cohort study. Ther Apher Dial. 2020;24(4):431–438. doi: 10.1111/1744-9987.13455.
   PubMed Web of Science ®Google Scholar
• Liu Y, Coresh J, Eustace JA, et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA. 2004;291(4):451–459. doi: 10.1001/jama.291.4.451.
   PubMed Web of Science ®Google Scholar
• Prichard SS. Impact of dyslipidemia in end-stage renal disease. J Am Soc Nephrol. 2003;14(9 Suppl 4):S315–S320. doi: 10.1097/01.asn.0000081698.10331.83.
   PubMed Web of Science ®Google Scholar
• Xiao X, Zhang J, Ji S, et al. Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease. Front Endocrinol. 2022;13:1026995. doi: 10.3389/fendo.2022.1026995.
   PubMedGoogle Scholar
• Hu X, Yan J, Huang L, et al. INT-777 attenuates NLRP3-ASC inflammasome-mediated neuroinflammation via TGR5/cAMP/PKA signaling pathway after subarachnoid hemorrhage in rats. Brain Behav Immun. 2021;91:587–600. doi: 10.1016/j.bbi.2020.09.016.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang J, Lin X, et al. DCA-TGR5 signaling activation alleviates inflammatory response and improves cardiac function in myocardial infarction. J Mol Cell Cardiol. 2021;151:3–14. doi: 10.1016/j.yjmcc.2020.10.014.
   PubMed Web of Science ®Google Scholar
• Xia Y, Xu X, Guo Y, et al. Mesenchymal stromal cells overexpressing farnesoid X receptor exert cardioprotective effects against acute ischemic heart injury by binding endogenous bile acids. Adv Sci. 2022;9(24):e2200431. doi: 10.1002/advs.202200431.
   Web of Science ®Google Scholar